GBA1 and liver cancer: Silence of GBA1 could increase the cell vitality by 4.3-fold in Huh7s under sorafenib exposure, and overexpression of GBA1 revealed opposite effect (Fig. S5C–E), indicating that low expression of GBA1 could increase chemotherapy resistance of liver cancer cells against sorafenib.